AstraZeneca strikes deal for up to $18.5 billion to license weight-loss drugs from China's CSPC - Reuters

Reuters | Jan. 29, 2026, 8:35 p.m. | Original
AstraZeneca strikes deal for up to $18.5 billion to license weight-loss drugs from China's CSPC Reuters
Kss Line Wins 154 Billion Won Order - TradingView Indonesia stock exchange CEO resigns after $80 billion market rout - Reuters